Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

    ... from phagocytosis in vitro. However, in the high-risk refractory anemia with excess blasts (RAEB) stages of MDS, ...

    Research Article last updated 03/05/2013 - 9:20am.

  2. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA)

    ... untreated or in remission than in patients with refractory disease. Allogeneic HSCT leads to prolonged survival in close ...

    Research Article last updated 06/19/2014 - 12:29pm.

  3. Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease

    ... of 4.5 months) especially for patients who fail ( refractory /relapsed) HMT. The only potential curative treatment for MDS is ...

    Research Article last updated 01/20/2015 - 12:52pm.

  4. Anemia as the Main Manifestation of Myelodysplastic Syndromes

    ... Several new agents are under evaluation for ESA refractory /relapsed MDS patients, targeting different putative mechanisms ...

    Research Article last updated 12/02/2015 - 8:45am.

  5. Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

    ... of -7/del(7q), and French-American-British subtypes refractory anaemia with excess blasts (RAEB) and RAEB in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Management of acquired aplastic anemia in children

    ... agents provide multiple alternatives for treating refractory or relapsed patients. Regardless of the type of therapeutic ...

    Research Article last updated 02/04/2013 - 2:05pm.

  7. Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

    ... of SES on survival was more apparent for patients with refractory anemia with ringed sideroblasts-patients residing in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. hase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02381548 ...

    Clinical Trial last updated 05/03/2016 - 10:41am.

  9. Total Marrow Irradiation for Refractory Acute Leukemia

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT00686556 ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  10. Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02044796 ...

    Clinical Trial last updated 04/28/2016 - 1:17pm.